StonvexLoading…
StonvexStonvexStonvexCore line items from TAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.04B | $13.73B | $13.88B | $12.81B |
Operating Income | $-2.34B | $1.75B | $1.44B | $157.50M |
Net Income | $-2.14B | $1.12B | $948.90M | $-175.30M |
EPS (Diluted) | $-10.75 | $5.35 | $4.37 | $-0.81 |
Total Assets | $22.74B | $26.06B | $26.38B | $25.87B |
Total Liabilities | $12.20B | $12.61B | $12.94B | $12.95B |
Cash & Equivalents | $896.50M | $969.30M | $868.90M | $600.00M |
Free Cash Flow OCF − CapEx | $1.07B | $1.24B | $1.41B | $840.60M |
Shares Outstanding | 199.10M | 209.90M | 217.30M | 216.90M |